| Japan Corporate News Network |
|
|
|
|
|
|
|
 |
|
 |
|
| FANCL, Tokyo University of Agriculture and Technology Confirm Cholesterol-lowering Mechanism of Germinated Brown Rice |
|
|
|
Tokyo, Apr 7, 2005 (JCN) - FANCL announced on April 6 that the company has confirmed a mechanism in which germinated brown rice lowers the level of blood cholesterol.
In collaboration with the Tokyo University of Agriculture and Technology, FANCL conducted mice experiments. The experiment results showed that an intake of germinated brown rice enhances the biosynthesis of bile acid using cholesterol, and promotes fecal steroid excretion including bile acid.
Based on these findings, the joint research group has concluded that, by eliminating excess cholesterol, germinated brown rice helps lower the level of blood cholesterol.
Detailed research results were presented at the Annual Meeting of Japan Society for Bioscience, Biotechnology, and Agrochemistry 2005 held in Sapporo, on March 30.
Copyright © 2010 JCN. All rights reserved. A division of Japan Corporate News Network KK.
 Company Profile |  Print |  Alerts
|
|
|
FANCL to Introduce New Additive-free Hair Care Series in June
(Apr 21, 2006)
|
|
|
FANCL Releases FANCL CLINICAiD, Nutritional Supplement Series Targeted at Medical Institutions
(Feb 15, 2006)
|
|
|
FANCL Announces Anti-atopic Dermatitis Effect of Kale Juice at Recent Academic Meeting
(Dec 13, 2005)
|
|
|
FANCL to Bring to Market New Antiaging Supplement in December
(Oct 6, 2005)
|
|
|
FANCL Announces Research Results of Antiaging Material Silybin at IFSCC International Conference 2005
(Oct 5, 2005)
|
|
|
FANCL's New Alpha Lipoic Acid-based Supplement to Go on Sale
(June 1, 2005)
|
|
|
FANCL, Hiroshima Prefectural University Confirm Anti-wrinkle and Skin Cell Protection Effects of Silymarin, Milk Thistle-derived Extract
(June 1, 2005)
|
|
|
FANCL Confirms that Secondhand Smoke Exposure Affects Dogs, Antioxidant Supplements Good for Those Affected Dogs
(May 19, 2005)
|
|
|
FANCL Confirms Brown Rice Properties Against Diabetic Nephropathy
(May 18, 2005)
|
|
|
FANCL Confirms Positive Effects of Long-term Intake of Germinated Brown Rice Against Diabetic Nephropathy
(May 16, 2005)
|
|
|
|
|
|
|
Asahi Kasei Integrates Bioprocess Businesses in North America (Dec 31, 2009)
|
|
|
Asahi Kasei Kuraray Medical Establishes Sales Subsidiary in Korea (Nov 1, 2009)
|
|
|
Asahi Kasei Launches 'Reveal DX' Insertable Cardiac Monitor (Oct 1, 2009)
|
|
|
New RIKEN Robot to Assist in Care Facilities (Sept 29, 2009)
|
|
|
Asahi Kasei Kuraray Medical Building Plant for Therapeutic Apheresis Devices (Sept 25, 2009)
|
|
|
Teijin Develops World's First Bioplastic Eyeglasses (Sept 4, 2009)
|
|
|
Astellas Establishes Fund Laboratory 'Genome Medical Science Laboratory' at the University of Tokyo (Sept 4, 2009)
|
|
|
Kuraray Mediacal Obtains Approval for Artificial Bone Graft (Sept 2, 2009)
|
|
|
Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania (Sept 2, 2009)
|
|
|
Pfizer and Astellas to Co-promote Hypertension, Hypercholesterolemia Treatment (Aug 31, 2009)
|
More Biotech news...
|
|
|
|
|
|
Asahi Kasei Integrates Bioprocess Businesses in North America (Dec 31, 2009)
|
|
|
Asahi Kasei Kuraray Medical Establishes Sales Subsidiary in Korea (Nov 1, 2009)
|
|
|
Asahi Kasei Launches 'Reveal DX' Insertable Cardiac Monitor (Oct 1, 2009)
|
|
|
New RIKEN Robot to Assist in Care Facilities (Sept 29, 2009)
|
|
|
Asahi Kasei Kuraray Medical Building Plant for Therapeutic Apheresis Devices (Sept 25, 2009)
|
|
|
Teijin Develops World's First Bioplastic Eyeglasses (Sept 4, 2009)
|
|
|
Astellas Establishes Fund Laboratory 'Genome Medical Science Laboratory' at the University of Tokyo (Sept 4, 2009)
|
|
|
Kuraray Mediacal Obtains Approval for Artificial Bone Graft (Sept 2, 2009)
|
|
|
Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania (Sept 2, 2009)
|
|
|
Pfizer and Astellas to Co-promote Hypertension, Hypercholesterolemia Treatment (Aug 31, 2009)
|
More Biotech news...
|
|
| |
|
|
|
|
|
